Business
Early Warning News Release - Dr. Albert D. Friesen Holdings in Medicure Inc.
Early Warning News Release - Dr. Albert D. Friesen Holdings in Medicure Inc. Canad...
About this update from Medicure Inc.
[{"type":"text","content":"\n\n\n\nEarly Warning News Release - Dr. Albert D. Friesen Holdings in Medicure Inc.\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nWINNIPEG, Dec. 31, 2019\n\n\n\nWINNIPEG, Dec. 31, 2019 /CNW/ - This press release is being issued in connection with the filing of an early warning report (the \"Early Warning Report\") pursuant to the requirements of National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues regarding the change in the ownership and control of common shares (the \"Common Shares\") of Medicure Inc. (the \"Issuer\") by Dr. Albert D. Friesen (\"Dr. Friesen\"). The Issuer's head office address and Dr. Friesen's business address is 2-1250 Waverley Street, Winnipeg, Manitoba, Canada, R3T 6C6.\nOn December 20, 2019, the Issuer announced the completion of its substantial issuer bid (the \"Offer\") pursuant to which the Issuer purchased for cancellation 4,000,000 of its outstanding Common Shares at a price of CDN$6.50 per Common Share.\nOn December 30, 2019, CentreStone Ventures Limited Partnership Fund (\"CentreStone\") disposed of a total of 42,128 Common Shares (representing 0.3% of the issued and outstanding Common Shares before giving effect to the Offer) under the Offer at a price of CDN$6.50 per Common Share, or CDN$273,832 in the aggregate. Dr. Friesen is the Chief Executive Officer of CentreStone Ventures Inc., the general partner of CentreStone and therefore has direction over, but not ownership of, the Common Shares disposed of by CentreStone under the Offer. \nNo other Common Shares owned, directly or indirectly, or controlled or directed by Dr. Friesen were otherwise tendered or disposed of under the Offer. \nImmediately prior to the completion of the Offer, Dr. Friesen had ownership of, directly and indirectly, or exercised control or direction over, 2,375,355 Common Shares (representing 16.0% of the issued and outstanding Common Shares before giving effect to the Offer). \nImmediately after completion of the Offer, Dr. Friesen has ownership of, directly and indirect...